Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas W Morrell

Showing results (241-250 of 278) with videos related to

Pageof 28
Sort By:
Human Mutation|September 22, 2015
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic DefectsRajiv D Machado, Laura Southgate, Christina A Eichstaedt, et al.
Human Mutation|September 8, 2011
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertensionMd Talat Nasim, Takeshi Ogo, Mohammad Ahmed, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 27, 2015
Long-term safety and efficacy of imatinib in pulmonary arterial hypertensionAdaani E Frost, Robyn J Barst, Marius M Hoeper, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
Circulation|October 4, 2017
Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2Paola Caruso, Benjamin J Dunmore, Kenny Schlosser, et al.
Circulation|November 25, 2016
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J Rhodes, Pavandeep Ghataorhe, John Wharton, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Integrative Multiomics to Dissect the Lung Transcriptional Landscape of Pulmonary Arterial HypertensionJason Hong, Brenda Wong, Christopher J Rhodes, et al.
Nature Communications|January 6, 2024
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertensionAnna Ulrich, Yukyee Wu, Harmen Draisma, et al.
Genome Medicine|May 11, 2021
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAHNa Zhu, Emilia M Swietlik, Carrie L Welch, et al.
Genome Medicine|June 23, 2021
Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAHNa Zhu, Emilia M Swietlik, Carrie L Welch, et al.
Pageof 28

Showing results (241-250 of 278) with videos related to

Sort By:
Pageof 28
Human Mutation|September 22, 2015
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic DefectsRajiv D Machado, Laura Southgate, Christina A Eichstaedt, et al.
Human Mutation|September 8, 2011
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertensionMd Talat Nasim, Takeshi Ogo, Mohammad Ahmed, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 27, 2015
Long-term safety and efficacy of imatinib in pulmonary arterial hypertensionAdaani E Frost, Robyn J Barst, Marius M Hoeper, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
Circulation|October 4, 2017
Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2Paola Caruso, Benjamin J Dunmore, Kenny Schlosser, et al.
Circulation|November 25, 2016
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J Rhodes, Pavandeep Ghataorhe, John Wharton, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Integrative Multiomics to Dissect the Lung Transcriptional Landscape of Pulmonary Arterial HypertensionJason Hong, Brenda Wong, Christopher J Rhodes, et al.
Nature Communications|January 6, 2024
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertensionAnna Ulrich, Yukyee Wu, Harmen Draisma, et al.
Genome Medicine|May 11, 2021
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAHNa Zhu, Emilia M Swietlik, Carrie L Welch, et al.
Genome Medicine|June 23, 2021
Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAHNa Zhu, Emilia M Swietlik, Carrie L Welch, et al.
Pageof 28